首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinics and research in hepatology and gastroenterology

缩写:CLIN RES HEPATOL GAS

ISSN:2210-7401

e-ISSN:2210-741X

IF/分区:2.4/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2449
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Apostolis Papaefthymiou,Aris Doukatas,Michail Galanopoulos Apostolis Papaefthymiou
Pancreatic cancer (PC) represents a malignancy with increased mortality rate, as less than 10% of patients survive for 5 years after diagnosis. Current evolution in basic sciences has revealed promising results by decrypting genetic loci vu...
Hang Jiang,Wei Li,Zhiqian Xue et al. Hang Jiang et al.
Background: Cholangiocarcinoma (CCA) is of great malignancy and high mortality. Identification of effective biomarkers could improve the monitoring of CCA development and attenuate patients' outcomes. ...
Tingbang He,Deguo Yu,Zhenfeng Wang et al. Tingbang He et al.
Background: Chaperonin-containing tailless complex polypeptide 1 subunit 6A (CCT6A) promotes several gastrointestinal-cancer malignant behaviors, while its clinical value in surgical gastric cancer is not clear. Hence, we...
Lei Sun,Chaohua Deng,Yunpeng Gu et al. Lei Sun et al.
Background: Dapagliflozin as a treatment option in patients with nonalcoholic fatty liver disease (NAFLD) has received increasing attention, however, the efficacy and safety of dapagliflozin for NAFLD has not been well as...
Helena Moreira-Silva,João Amorim,Ermelinda Santos-Silva Helena Moreira-Silva
Incidental liver lesions are increasingly being discovered in the context of the increased use of ultrasound studies and the majority are benign. In children, although individually rare, the differential diagnosis is broad and therefore a s...
Wang Li,Lei Ou,Yu Fu et al. Wang Li et al.
Objective: Acute pancreatitis (AP) is a self-limiting disease. However, 20-30% of patients will develop into severe AP (SAP), and infectious pancreatic necrosis in the late course of SAP is the leading cause of death for ...